{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T22:11:45Z","timestamp":1787523105720,"version":"build-2736575974"},"publisher-location":"Berlin, Heidelberg","reference-count":56,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642181061","type":"print"},{"value":"9783642181078","type":"electronic"}],"license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/128_2010_89","type":"book-chapter","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T11:33:08Z","timestamp":1282735988000},"page":"93-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["14-Amino-4,5-Epoxymorphinan Derivatives and Their Pharmacological Actions"],"prefix":"10.1007","author":[{"given":"John W.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Husbands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,26]]},"reference":[{"key":"89_CR1_89","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1213\/ane.0b013e31819e0d3a","volume":"108","author":"ER Viscusi","year":"2009","unstructured":"Viscusi ER, Gan TJ, Leslie JB, Foss JF, Talon MD, Du W, Owens G (2009) Peripherally acting \u03bc-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability. Anesth Analg 108:1811\u20131822","journal-title":"Anesth Analg"},{"key":"89_CR2_89","doi-asserted-by":"crossref","first-page":"68T","DOI":"10.1111\/j.2042-7158.1964.tb07539.x","volume":"16","author":"WR Buckett","year":"1964","unstructured":"Buckett WR (1964) The relationship between analgesic activity, acute toxicity and chemical structure in esters of 14-hydroxycodeinone. J Pharm Pharmacol 16:68T\u201371T","journal-title":"J Pharm Pharmacol"},{"key":"89_CR3_89","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.2042-7158.1965.tb07602.x","volume":"17","author":"WR Buckett","year":"1965","unstructured":"Buckett WR (1965) Some pharmacological studies with 14-(cinnamoyloxy)codeinone. J Pharm Pharmacol 17:759\u2013760","journal-title":"J Pharm Pharmacol"},{"key":"89_CR4_89","first-page":"419","volume":"1","author":"WR Buckett","year":"1972","unstructured":"Buckett WR, Bosman HH (1972) New morphinone derivatives and their preparation. UK Patent 1 300 419","journal-title":"UK Patent"},{"key":"89_CR5_89","first-page":"1411","volume":"D","author":"KW Bentley","year":"1969","unstructured":"Bentley KW, Horsewood P, Kirby GW, Singh S (1969) Diels-Alder adducts from thebaine and nitroso-arenes. J Chem Soc D:1411","journal-title":"J Chem Soc"},{"key":"89_CR6_89","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1021\/jm00180a028","volume":"23","author":"L Schwab","year":"1980","unstructured":"Schwab L (1980) 14-(Arylhydroxyamino)codeinones and derivatives as analgetics and antagonists. J Med Chem 23:698\u2013702","journal-title":"J Med Chem"},{"key":"89_CR7_89","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1039\/p19810001143","volume":"26","author":"RM Allen","year":"1981","unstructured":"Allen RM, Kirby GW, McDougall DJ (1981) The nitration of thebaine with tetranitromethane. J Chem Soc Perkin Trans I 26:1143\u20131147","journal-title":"J Chem Soc Perkin Trans I"},{"key":"89_CR8_89","unstructured":"Kobylecki RJ, Guest IG, Lewis JW, Kirby GW (1980) 14-Amino derivatives of morphine, methods of making them and analgesic compositions containing them. US Patent 4241066"},{"key":"89_CR9_89","unstructured":"Kobylecki RJ, Guest IG, Lewis JW, Kirby GW (1980) 14-Amino derivatives of morphine, methods of making them and analgesic compositions containing them. US Patent 4241067"},{"key":"89_CR10_89","doi-asserted-by":"crossref","unstructured":"Horsewood P, Kirby GW (1980) Preparation of 14-beta-hydroxyamino and 14-beta-aminocodeinone from thebaine. J Chem Res (S) 401:(M)4880","DOI":"10.1002\/chin.198113377"},{"key":"89_CR11_89","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1021\/jm00366a024","volume":"26","author":"S Archer","year":"1983","unstructured":"Archer S, Seyed-Mozaffari A, Osei-Gyimah P, Bidlack JM, Abood LG (1983) 14\u03b2-(2-Bromoacetamido)morphine and 14\u03b2-(2-bromoacetamido)morphinone. J Med Chem 26:1775\u20131777","journal-title":"J Med Chem"},{"key":"89_CR12_89","doi-asserted-by":"crossref","unstructured":"Kirby GW, Sweeney JG (1973) Nitrosocarbonyl compounds as intermediates in the oxidative cleavage of hydroxamic acids. J Chem Soc Chem Commun:704\u2013705","DOI":"10.1039\/c39730000704"},{"key":"89_CR13_89","doi-asserted-by":"crossref","unstructured":"Kirby GW, McLean D (1985) An efficient synthesis of 14\u03b2-aminocodeinone from thebaine. J Chem Soc Perkin Trans I 1443\u20131445","DOI":"10.1039\/P19850001443"},{"key":"89_CR14_89","first-page":"136","volume":"90","author":"J Lewis","year":"1988","unstructured":"Lewis J, Smith C, McCarthy P, Walter D, Kobylecki R, Myers M, Haynes A, Lewis C, Waltham K (1988) New 14-aminomorphinones and codeinones. NIDA Res Monogr 90:136\u2013143","journal-title":"NIDA Res Monogr"},{"key":"89_CR15_89","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1021\/jm00073a015","volume":"36","author":"A Sebastian","year":"1993","unstructured":"Sebastian A, Bidlack JM, Jiang Q, Deecher D, Teitler M, Glick SD, Archer S (1993) 14\u03b2-[(p-Nitrocinnamoyl)amino]morphinones, 14\u03b2-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activity. J Med Chem 36:3154\u20133160","journal-title":"J Med Chem"},{"key":"89_CR16_89","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/0960-894X(95)00287-4","volume":"5","author":"JM Bidlack","year":"1995","unstructured":"Bidlack JM, Kaplan RA, Sebastian A, Seyed-Mozaffari A, Hutchinson I, Archer S (1995) N-Mmethyl and N-cyclopropylmethyl-14\u03b1, 14\u2032\u03b2-[dithiobis[(2-oxo-2, 1-ethanediyl)imino]]bis(7,8-dihydro-5\u03b2-methyl-morphinone) MET-TAMO and N-CPM-MET-TAMO: synthesis and opioid binding properties. Bioorg Med Chem Lett 5:1695\u20131700","journal-title":"Bioorg Med Chem Lett"},{"key":"89_CR17_89","unstructured":"Nieland N (1998) Investigations of derivatives of 14\u03b2-amino-7,8-dihydromorphinone. PhD Thesis, University of Bristol"},{"key":"89_CR18_89","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.1021\/jm060595u","volume":"49","author":"D Rennison","year":"2006","unstructured":"Rennison D, Moynihan H, Traynor JR, Lewis JW, Husbands SM (2006) Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the C14-amino to aryl ring linker chain. J Med Chem 49:6104\u20136110","journal-title":"J Med Chem"},{"key":"89_CR19_89","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.1021\/jm0604777","volume":"49","author":"NPR Nieland","year":"2006","unstructured":"Nieland NPR, Moynihan H, Carrington S, Broadbear J, Woods JH, Traynor JR, Husbands SM, Lewis JW (2006) Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones. J Med Chem 49:5333\u20135338","journal-title":"J Med Chem"},{"key":"89_CR20_89","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1021\/jm021073r","volume":"43","author":"P Grundt","year":"2003","unstructured":"Grundt P, Jales AJ, Traynor JR, Lewis JW, Husbands SM (2003) 14-Amino, 14-alkylamino- and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profiles. J Med Chem 43:1563\u20131566","journal-title":"J Med Chem"},{"key":"89_CR21_89","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1021\/jm9810248","volume":"41","author":"SM Husbands","year":"1998","unstructured":"Husbands SM, Sadd J, Broadbear JH, Woods JH, Martin J, Traynor JR, Aceto MD, Bowman ER, Harris LS, Lewis JW (1998) 3-Alkyl ethers of clocinnamox: delayed long-term \u03bc-antagonists with variable \u03bc efficacy. J Med Chem 41:3493\u20133498","journal-title":"J Med Chem"},{"key":"89_CR22_89","first-page":"578","volume":"95","author":"MD Aceto","year":"1989","unstructured":"Aceto MD, Bowman ER, Harris LS, May EL (1989) Dependence studies of new compounds in the rhesus monkey, rat and mouse. NIDA Res Monogr 95:578","journal-title":"NIDA Res Monogr"},{"key":"89_CR23_89","first-page":"570","volume":"39","author":"MD Aceto","year":"1989","unstructured":"Aceto MD, Bowmen ER, May EL, Woods JH, Smith CB, Medzihradsky F, Jacobson AE (1989) Very long-acting narcotic antagonists: the 14\u03b2-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives. Arzneim-Forsch Drug Res 39:570\u2013575","journal-title":"Arzneim-Forsch Drug Res"},{"key":"89_CR24_89","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3565(24)38137-6","volume":"289","author":"JP McLaughlin","year":"1999","unstructured":"McLaughlin JP, Hill KP, Jiang Q, Sebastian A, Archer S, Bidlack JM (1999) Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of \u03bc-selective agonist and antagonist activity. J Pharmacol Exp Ther 289:304\u2013311","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR25_89","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0022-3565(25)10898-7","volume":"262","author":"SD Comer","year":"1992","unstructured":"Comer SD, Burke TF, Lewis JW, Woods JH (1992) Clocinnamox: a novel, systemically active irreversible opioid antagonist. J Pharmacol Exp Ther 262:1051\u20131056","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR26_89","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3565(25)23819-8","volume":"271","author":"TF Burke","year":"1994","unstructured":"Burke TF, Woods JH, Lewis JW, Medzihradsky F (1994) Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice. J Pharmacol Exp Ther 271:715\u2013721","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR27_89","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/0024-3205(95)02204-V","volume":"57","author":"G Zernig","year":"1995","unstructured":"Zernig G, Issaevitch T, Broadbear JH, Burke TF, Lewis JW, Brine GA, Woods JH (1995) Receptor reserve and affinity of mu-opioid agonists in mouse antinociception \u2013 correlation with receptor-binding. Life Sci 57:2113\u20132125","journal-title":"Life Sci"},{"key":"89_CR28_89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-3565(25)38710-0","volume":"269","author":"G Zernig","year":"1994","unstructured":"Zernig G, Butelman ER, Lewis JW, Walker EA, Woods JH (1994) In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. J Pharmacol Exp Ther 269:57\u201365","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR29_89","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0022-3565(24)37502-0","volume":"285","author":"RC Pitts","year":"1998","unstructured":"Pitts RC, Allen RM, Walker EA, Dykstra LA (1998) Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys. J Pharmacol Exp Ther 285:1197\u20131206","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR30_89","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1124\/jpet.102.047068","volume":"305","author":"AC Barrett","year":"2003","unstructured":"Barrett AC, Smith ES, Picker MJ (2003) Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox. J Pharmacol Exp Ther 305:1061\u20131070","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR31_89","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1124\/jpet.302.1.101","volume":"302","author":"EA Walker","year":"2002","unstructured":"Walker EA, Young AM (2002) Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine. J Pharmacol Exp Ther 302:101\u2013110","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR32_89","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-3565(24)39155-4","volume":"294","author":"JH Broadbear","year":"2000","unstructured":"Broadbear JH, Sumpter TL, Burke TF, Husbands SM, Lewis JW, Woods JH, Traynor JR (2000) Methcinnamox is a potent, long-lasting and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, \u03b2-FNA and \u03b2-chlornaltrexamine. J Pharmacol Exp Ther 294:933\u2013940","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR33_89","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","volume":"282","author":"J Zhu","year":"1997","unstructured":"Zhu J, Lou L-Y, Li J-G, Chen C, Liu-Chen L-Y (1997) Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTP\u03b3S binding to membranes: determination of potencies and efficacies of ligands. J Pharmacol Exp Ther 282:676\u2013684","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR34_89","first-page":"440","volume":"178","author":"L Toll","year":"1998","unstructured":"Toll L, Berzetei-Gurske IP, Plogar WE, Brandt SR, Adapa ID, Rodriguez L, Schwartz W, Haggart D, O\u2019Brien A, White A, Kennedy JM, Craymer K, Farrington L, Auh JS (1998) Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA Res Monogr 178:440\u2013445","journal-title":"NIDA Res Monogr"},{"key":"89_CR35_89","first-page":"195","volume":"147","author":"JH Woods","year":"1995","unstructured":"Woods JH, Lewis JW, Winger G, Butelman E, Broadbear J, Zernig G (1995) Methoclocinnamox: a \u03bc partial agonist with pharmacotherapeutic potential for heroin abuse. NIDA Res Monogr 147:195\u2013219","journal-title":"NIDA Res Monogr"},{"key":"89_CR36_89","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0376-8716(89)90076-8","volume":"24","author":"G Winger","year":"1992","unstructured":"Winger G, Palmer RK, Woods JH (1992) Drug-reinforced responding: rapid determination of dose-response functions. Drug Alcohol Depend 24:135\u201342","journal-title":"Drug Alcohol Depend"},{"key":"89_CR37_89","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/1389557033405395","volume":"3","author":"SM Husbands","year":"2003","unstructured":"Husbands SM, Lewis JW (2003) Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse. Min Rev Med Chem 3:137\u2013144","journal-title":"Min Rev Med Chem"},{"key":"89_CR38_89","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1021\/jm0009641","volume":"43","author":"I Derrick","year":"2000","unstructured":"Derrick I, Neilan CL, Andes J, Husbands SM, Woods JH, Traynor JR, Lewis JW (2000) 3-Deoxyclocinnamox: the first selective, high affinity, non-peptidic, \u03bc-opioid antagonist lacking a phenolic hydroxyl group. J Med Chem 43:3348\u20133350","journal-title":"J Med Chem"},{"key":"89_CR39_89","first-page":"67","volume":"152","author":"JW Lewis","year":"1995","unstructured":"Lewis JW, Husbands SM, Broadbear J, Woods JH (1995) Opioids \u2013 from analgesics to treatment drugs. Franklin M Robinson Memorial Symposium. NIDA Res Monogr 152:67","journal-title":"NIDA Res Monogr"},{"key":"89_CR40_89","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1021\/jm8012272","volume":"52","author":"H Moynihan","year":"2009","unstructured":"Moynihan H, Jales AR, Greedy BM, Broadbear JH, Purington L, Traynor JR, Woods JH, Lewis JW, Husbands SM (2009) 14\u03b2-O-Cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity. J Med Chem 52:1553\u20131557","journal-title":"J Med Chem"},{"key":"89_CR41_89","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1021\/jm021118o","volume":"46","author":"E Greiner","year":"2003","unstructured":"Greiner E, Spetea M, Krassnig R, Schullner F, Aceto M, Harris LS, Traynor JR, Woods JH, Coop A, Schmidhammer H (2003) Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-Substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships. J Med Chem 46:1758\u20131763","journal-title":"J Med Chem"},{"key":"89_CR42_89","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-3565(25)38586-1","volume":"268","author":"Q Jiang","year":"1994","unstructured":"Jiang Q, Sebastian A, Archer S, Bidlack JM (1994) 5\u03b2-Methyl-14\u03b2-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analogue, N-cyclopropylmethylnor-5\u03b2-methyl-14\u03b2-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: mu selective irreversible opioid antagonists. J Pharmacol Exp Ther 268:1107\u20131113","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR43_89","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0014-2999(96)00904-1","volume":"320","author":"JP McLaughlin","year":"1997","unstructured":"McLaughlin JP, Sebastian A, Archer S, Bidlack JM (1997) 14 Beta-chlorocinnamoylamino derivatives of metopon: long-term mu-opioid receptor antagonists. Eur J Pharmacol 320:121\u2013129","journal-title":"Eur J Pharmacol"},{"key":"89_CR44_89","first-page":"43","volume":"1","author":"JM Bidlack","year":"1991","unstructured":"Bidlack JM, Seyed-Mozaffari A, Archer S (1991) 14\u03b2-Thioglycolamido-7, 8-dihydromorphinone, a \u03bc-selective irreversible ligand. Med Chem Res 1:43\u201346","journal-title":"Med Chem Res"},{"key":"89_CR45_89","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-3565(25)10789-1","volume":"262","author":"Q Jiang","year":"1992","unstructured":"Jiang Q, Seyedmozaffari A, Archer S, Bidlack JM (1992) Antinociceptive properties of 2 alkylating derivatives of morphinone \u2013 14-beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14-beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO). J Pharmacol Exp Ther 262:526\u2013531","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR46_89","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0022-3565(25)10108-0","volume":"264","author":"Q Jiang","year":"1993","unstructured":"Jiang Q, Seyedmozaffari A, Archer S, Bidlack JM (1993) Pharmacological study of 14-beta-(thioglycolamido)-7,8-dihydro-n-cyclopropylmethyl-normorphinone (N-CPM-TAMO). J Pharmacol Exp Ther 264:1021\u20131027","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR47_89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0026-895X(25)09937-7","volume":"37","author":"JM Bidlack","year":"1989","unstructured":"Bidlack JM, Frey DK, Kaplan RA, Seyed-Mozaffari A, Archer S (1989) Affinity labelling of mu opioid receptors by sulhydryl alkylating derivatives of morphine and morphinone. Mol Pharmacol 37:50\u201359","journal-title":"Mol Pharmacol"},{"key":"89_CR48_89","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1021\/jm00037a008","volume":"37","author":"S Archer","year":"1994","unstructured":"Archer S, Seyedmozaffari A, Jiang Q, Bidlack JM (1994) 14-Alpha, 14\u2032beta-[dithiobis[(2-oxo-2, 1-ethanediyl)imino]]bis (7,8-dihydromorphinone) and 14-alpha, 14\u2032beta-[dithiobis[(2-oxo-2, 1-ethanediyl)imino]]bis[7,8-dihydro-n-(cyclopropylmethyl)normorphinone] \u2013 chemistry and opioid binding-properties. J Med Chem 37:1578\u20131585","journal-title":"J Med Chem"},{"key":"89_CR49_89","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0022-3565(25)20780-7","volume":"278","author":"MB Gatch","year":"1996","unstructured":"Gatch MB, Negus SS, Mello NK, Archer S, Bidlack JM (1996) Effects of the structurally novel opioid 14 alpha, 14\u2032beta-[dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) schedule-controlled behavior and thermal nociception in rhesus monkeys. J Pharmacol Exp Ther 278:1282\u20131289","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR50_89","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-3565(25)09535-7","volume":"273","author":"Q Jiang","year":"1995","unstructured":"Jiang Q, Seyedmozaffari A, Sebastian A, Archer S, Bidlack JM (1995) Preventing morphine antinociceptive tolerance by irreversible mu-opioid antagonists before the onset of their antagonism. J Pharmacol Exp Ther 273:680\u2013688","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR51_89","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0022-3565(25)21160-0","volume":"279","author":"JY Xu","year":"1996","unstructured":"Xu JY, SeyedMozaffari A, Archer S, Bidlack JM (1996) N-Cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term mu-selective irreversible opioid antagonist. J Pharmacol Exp Ther 279:539\u2013547","journal-title":"J Pharmacol Exp Ther"},{"key":"89_CR52_89","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/0960-894X(96)00186-2","volume":"6","author":"S Archer","year":"1996","unstructured":"Archer S, Glick SD, Maisonneuve IM, Bidlack JM, Xu JY, Teitler M, Sebastian A, ElHamouly W, Hutchinson I (1996) Suppression of morphine and cocaine self-administration in rats by a mixed mu antagonist kappa agonist (N-CBM-TAMO) and a long-acting selective D-1 antagonist (AS-300). Bioorg Med Chem Lett 6:1139\u20131144","journal-title":"Bioorg Med Chem Lett"},{"key":"89_CR53_89","first-page":"72","volume":"180","author":"JW Lewis","year":"2000","unstructured":"Lewis JW, Neiland NPR, Traynor JR, Woods JH (2000) Pyridylacryloyl derivatives of 14-\u03b2-aminomorphinones. NIDA Res Monogr 180:72","journal-title":"NIDA Res Monogr"},{"key":"89_CR54_89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0014-2999(95)00185-N","volume":"280","author":"TS Shippenberg","year":"1995","unstructured":"Shippenberg TS, Heidbreder C (1995) The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur J Pharmacol 280:55\u201361","journal-title":"Eur J Pharmacol"},{"key":"89_CR55_89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00213-002-1028-z","volume":"161","author":"T Mori","year":"2002","unstructured":"Mori T, Nomura M, Nagase H, Narita M, Suzuki T (2002) Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats. Psychopharmacol 161:17\u201322","journal-title":"Psychopharmacol"},{"key":"89_CR56_89","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0960-894X(01)00112-3","volume":"11","author":"J Clayson","year":"2001","unstructured":"Clayson J, Jales A, Tyacke RJ, Hudson AL, Nutt DJ, Lewis JW, Husbands SM (2001) Selective \u03b4-opioid receptor ligands: potential PET ligands based on naltrindole. Bioorg Med Chem Lett 11:939\u2013943","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Topics in Current Chemistry","Chemistry of Opioids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/128_2010_89","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T01:07:26Z","timestamp":1740445646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/128_2010_89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9783642181061","9783642181078"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/128_2010_89","relation":{},"ISSN":["0340-1022","1436-5049"],"issn-type":[{"value":"0340-1022","type":"print"},{"value":"1436-5049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]},"assertion":[{"value":"26 August 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}